Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women

  1. Graziano Di Cianni, MD,
  2. Laura Volpe, MD,
  3. Cristina Lencioni, MD,
  4. Kyriazoula Chatzianagnostou, MD,
  5. Ilaria Cuccuru, MD,
  6. Alessandra Ghio, MD,
  7. Luca Benzi, MD and
  8. Stefano Del Prato, MD
  1. From the Department of Endocrinology and Metabolism, Section of Diabetes, University of Pisa, Pisa, Italy
  1. Address correspondence to Dr. Graziano Di Cianni, Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, Ospedale di Cisanello, Via Paradisa, 2, I-56126 Pisa, Italy. E-mail: dicianni{at}immr.med.unipi.it
Diabetes Care 2005 Apr; 28(4): 982-983. https://doi.org/10.2337/diacare.28.4.982
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Tables

  • Table 1—

    Clinical characteristics of five type 1 diabetic pregnancies

    PatientAge (years)/ white class*HbA1c preconception/ end of pregnancy (%)Use of glargine in pregnancy (weeks)Glargine dose in pregnancy (IU/day)Time of delivery (weeks)Newborn weight (g)Perinatal mortality and/or congenital malformation
    132/B7.0/6.7618352,220No
    226/C6.4/6.41256373,500No
    341/C7.0/6.2818384,400No
    432/D7.6/5.8614372,850No
    527/B8.7/5.8620362,360No
    • *

      ↵* White Classification of Diabetes in Pregnancy (7). Class A: Diet alone, any duration or onset age. Class B: Onset at age ≥20 years, duration <10 years. Class C: Onset between the ages of 10 and 19 years, duration 10–19 years. Class D: Onset before the age of 10 years, duration <20 years, background retinopathy or hypertension (not pre-eclampsia). Class R: Proliferative retinopathy or vitreous hemorrhage. Class F: Nephropathy with >500 mg/day proteinuria. Class RF: Criteria for both classes R and F coexist. Class H: Arteriosclerotic hearth disease clinically evident. Class T: Prior renal transplantation. All classes below A require insulin therapy.

PreviousNext
Back to top
Diabetes Care: 28 (4)

In this Issue

April 2005, 28(4)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women
Graziano Di Cianni, Laura Volpe, Cristina Lencioni, Kyriazoula Chatzianagnostou, Ilaria Cuccuru, Alessandra Ghio, Luca Benzi, Stefano Del Prato
Diabetes Care Apr 2005, 28 (4) 982-983; DOI: 10.2337/diacare.28.4.982

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Use of Insulin Glargine During the First Weeks of Pregnancy in Five Type 1 Diabetic Women
Graziano Di Cianni, Laura Volpe, Cristina Lencioni, Kyriazoula Chatzianagnostou, Ilaria Cuccuru, Alessandra Ghio, Luca Benzi, Stefano Del Prato
Diabetes Care Apr 2005, 28 (4) 982-983; DOI: 10.2337/diacare.28.4.982
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
  • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
  • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
Show more Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.